Rezultati - K. Serhal

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01)

    189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-... od B. Pistilli, Nusaïbah Ibrahimi, M. Lacroix-Triki, Véronique D’Hondt, Cécile Vicier, Jean‐Sébastien Frénel, Florence Dalenc, Thomas Bachelot, M-A. Benderra, Delphine Loirat, Agnès Ducoulombier, Didier Mayeur, Ghada Nachabeh, K. Serhal, Noémie Corcos, Dalila Sellami, Stefan Michiels, Fabrice André, M.F. Mosele, Guillaume Montagnac

    Izdano 2023
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: